首页> 美国卫生研究院文献>MedChemComm >DIBI a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity
【2h】

DIBI a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity

机译:DIBI具有增强的抗菌活性的3-羟基吡啶-4-酮一螯合剂铁结合聚合物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Depriving microorganisms of bioavailable iron is a promising strategy for new anti-infective agents. The new, highly water-soluble, low molecular weight co-polymer DIBI was developed to selectively bind iron(iii) ions as a tris chelate and acts as a standalone anti-infective. Minimum inhibitory concentration (MIC) studies show DIBI is effective against representative reference strains for Gram-positive and Gram-negative bacteria S. aureus and A. baumannii, and the fungus C. albicans. Compared to the small molecule iron chelators, deferiprone and deferoxamine, DIBI outclassed these by factors of 100 to 1000 for inhibition of initial growth. DIBI and a series of related co-polymers (Mw of 2–9 kDa) were synthesized via reversible addition–fragmentation chain transfer (RAFT) polymerization of a chelating 3-hydroxypyridin-4-one (HPO) methacrylamide monomer and N-vinylpyrrolidone (NVP). Full incorporation of the HPO monomer into the co-polymers from the reaction solution was determined by 1H NMR spectroscopy and ranged from 4.6 to 25.6 mol%. UV-vis spectroscopy showed that all the HPO in DIBI binds readily to iron(iii) in a tris chelate mode to the maximum theoretical iron(iii) binding capacity of the co-polymer. Chemical characterization including single crystal X-ray diffraction analyses of the O-benzyl protected and the functional HPO monomer are discussed. By design, DIBI is highly water soluble; the highest mass fraction in water tested was 70% w/w, without the need of organic co-solvents.
机译:剥夺微生物的生物利用铁是一种新的抗感染剂的有前途的策略。新型的高度水溶性,低分子量的共聚物DIBI可以选择性结合铁离子(tris)作为Tris螯合物,并具有独立的抗感染性。最小抑菌浓度(MIC)研究表明,DIBI对革兰氏阳性和革兰氏阴性细菌金黄色葡萄球菌和鲍曼不动杆菌以及真菌白色念珠菌具有代表性的参考菌株有效。与小分子铁螯合剂,去铁酮和去铁胺相比,DIBI在抑制初始生长方面的优势要高100到1000倍。 DIBI和一系列相关的共聚物(Mw为2–9 kDa)是通过螯合的3-羟基吡啶-4-酮(HPO)甲基丙烯酰胺单体和N-乙烯基吡咯烷酮的可逆加成-断裂链转移(RAFT)聚合合成的( NVP)。通过 1 NMR光谱确定HPO单体从反应溶液中完全掺入到共聚物中,其范围为4.6至25.6mol%。紫外-可见光谱表明,DIBI中的所有HPO均以三螯合模式容易地与铁(iii)结合,达到共聚物的最大理论铁(iii)结合能力。讨论了化学表征,包括被保护的O-苄基和功能HPO单体的单晶X射线衍射分析。根据设计,DIBI具有高度的水溶性。在测试的水中,最高质量分数为70%w / w,而无需有机助溶剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号